NANOVIRICIDES, INC. Deferred Compensation Arrangement with Individual, Shares Authorized for Issuance
NANOVIRICIDES, INC. (NNVC) had Deferred Compensation Arrangement with Individual, Shares Authorized for Issuance of 26.25 thousand shares as of 2021-06-30, per its 10-K filed 2021-10-12.
Discontinued › Notes › Compensation Related Costs › General
us-gaap:DeferredCompensationArrangementWithIndividualSharesAuthorizedForIssuance · last filed 2021-10-12
- 2021-06-30: Deferred Compensation Arrangement with Individual, Shares Authorized for Issuance 26.25K shares.
- 2020-06-30: Deferred Compensation Arrangement with Individual, Shares Authorized for Issuance 26.25K shares.
- 2020-03-31: Deferred Compensation Arrangement with Individual, Shares Authorized for Issuance 26.25K shares.
- 2019-12-31: Deferred Compensation Arrangement with Individual, Shares Authorized for Issuance 26.25K shares.
| Period end | Deferred Compensation Arrangement with Individual, Shares Authorized for Issuance |
|---|---|
| 2021-06-30 | 26.25K shares 10-K · filed 2021-10-12 |
| 2020-06-30 | 26.25K shares 10-K · filed 2020-10-13 |
| 2020-03-31 | 26.25K shares 10-Q · filed 2020-06-22 |
| 2019-12-31 | 26.25K shares 10-Q · filed 2020-02-14 |
| 2019-09-30 | 26.25K shares 10-Q · filed 2019-11-15 |
| 2019-06-30 | 525.00K shares 10-K · filed 2019-08-23 |
| 2019-03-31 | 525.00K shares 10-Q · filed 2019-05-15 |
| 2018-12-31 | 525.00K shares 10-Q · filed 2019-02-14 |
| 2018-09-30 | 525.00K shares 10-Q · filed 2018-11-14 |
| 2018-06-30 | 225.00K shares 10-K · filed 2018-10-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |